AAAAAA
Results:
1-17
|
Results: 17
Authors:
Pujade-Lauraine, E
Cure, H
Battista, C
Guastalla, JP
Chiurazzi, B
Fabbro, M
Tubiana-Mathieu, N
Bourgeois, H
Lioure, B
Paraiso, D
Lotz, JP
Citation: E. Pujade-lauraine et al., High dose chemotherapy in ovarian cancer, INT J GYN C, 11, 2001, pp. 64-67
Authors:
Ledermann, JA
Herd, R
Maraninchi, D
Viens, P
Buclon, M
Philip, T
Cure, H
Lotz, JP
Chauvin, F
Ferrante, P
Rosti, G
Citation: Ja. Ledermann et al., High-dose chemotherapy for ovarian carcinoma: Long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT), ANN ONCOL, 12(5), 2001, pp. 693-699
Authors:
Bernard-Gallon, DJ
De Latour, MP
Hizel, C
Vissac, C
Cure, H
Pezet, D
Dechelotte, PJ
Chipponi, J
Chassagne, J
Bignon, YJ
Citation: Dj. Bernard-gallon et al., Localization of human BRCA1 and BRCA2 in non-inherited colorectal carcinomas and matched normal mucosas, ANTICANC R, 21(3B), 2001, pp. 2011-2020
Authors:
Le Bouedec, G
Auvray, H
Cure, H
de Latour, M
Penault-Llorca, F
Dauplat, J
Citation: G. Le Bouedec et al., Uterine sarcoma in patients receiving tamoxifen therapy: two cases., REV MED IN, 22(9), 2001, pp. 881-885
Authors:
Le Bouedec, GL
Cure, H
de Latour, M
Dauplat, J
Citation: Gl. Le Bouedec et al., Stewart-Treves syndrome postmastectomy for breast cancer. One case., REV MED IN, 22(8), 2001, pp. 753-757
Authors:
Cure, H
Bay, JO
Plagne, R
Chollet, P
Dauplat, J
Citation: H. Cure et al., High-dose chemotherapy in advanced epithelial ovarian cancer, B CANCER, 88(9), 2001, pp. 842-851
Authors:
Cutuli, B
Janvier, M
de la Rochefordiere, A
Julien, JP
Isambert, N
Alzieu, C
Kerbrat, P
de Lafontan, B
van Lemmens, L
Cure, H
Ganem, G
Baume, D
Le Mevel, A
Lorthoraly, A
de Gislain, C
Marchal, C
Chevelle, C
Lauche, H
Serin, D
Citation: B. Cutuli et al., Leukemias and preleukemic states developing after treatment of breast cancer, PRESSE MED, 29(3), 2000, pp. 135-138
Authors:
Charrier, S
Chollet, P
Bay, JO
Cure, H
Kwiatkowski, F
Portefaix, G
Communal, Y
Betail, G
Plagne, R
Chassagne, J
Citation: S. Charrier et al., Hematological recovery and peripheral blood progenitor cell mobilization after induction chemotherapy and GM-CSF plus G-CSF in breast cancer, BONE MAR TR, 25(7), 2000, pp. 705-710
Authors:
Cure, H
Chevalier, V
Pezet, D
Bousquet, J
Focan, C
Levi, F
Garufi, C
Chipponi, J
Chollet, P
Citation: H. Cure et al., Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer, ANTICANC R, 20(6C), 2000, pp. 4649-4653
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults
Authors:
Roche, H
Cure, H
Adenis, A
Fargeot, P
Terret, C
Lentz, MA
Madelmont, JC
Fumoleau, P
Hanauske, A
Chollet, P
Citation: H. Roche et al., Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults, J NEURO-ONC, 49(2), 2000, pp. 141-145
Authors:
Cure, H
Dauplat, J
Chollet, P
Citation: H. Cure et al., First line chemotherapy for advanced ovarian cancer in 2000: standards andquestions, B CANCER, 87(2), 2000, pp. 189-199
Authors:
Michallet, M
Tanguy, ML
Socie, G
Thiebaut, A
Belhabri, A
Milpied, N
Reiffers, J
Kuentz, M
Cahn, JY
Blaise, D
Demeocq, F
Jouet, JP
Michallet, AS
Ifrah, N
Vilmer, E
Molina, L
Michel, G
Lioure, B
Cavazzana-Calvo, M
Pico, JL
Sadoun, A
Guyotat, D
Attal, M
Cure, H
Bordigoni, P
Sutton, L
Buzyn-Veil, A
Tilly, M
Leporrier, M
Fegueux, N
Dreyfus, F
Rio, B
Lutz, P
Vernant, JP
Citation: M. Michallet et al., Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM), BR J HAEM, 108(2), 2000, pp. 400-407
Authors:
Lotz, JP
Cure, H
Janvier, M
Morvan, F
Legros, M
Asselain, B
Guillemot, M
Roche, H
Gisselbrecht, C
Citation: Jp. Lotz et al., High-dose chemotherapy with autologous hematopoietic stem cell support formetastatic breast cancer: Results of the French Pegase 04 protocol, HEM CELL TH, 41(2), 1999, pp. 71-74
Authors:
Cure, H
Souteyrand, P
Ouabdesselam, R
Roche, H
Ravaud, A
D'incan, M
Viens, P
Fargeot, P
Lentz, MA
Fumoleau, P
Hanauske, A
Chollet, P
Citation: H. Cure et al., Results of a phase II trial with cystemustine at 90 mg/m(2) as a first- orsecond-line treatment in advanced malignant melanoma: a trial of the EORTCClinical Studies Group, MELANOMA RE, 9(6), 1999, pp. 607-610
Authors:
Le Bouedec, G
Charrier, S
Cure, H
de Latour, MP
Ferriere, JP
Chollet, P
Dauplat, J
Citation: G. Le Bouedec et al., Role for surgery after complete clinical response to neoadjuvant chemotherapy for breast cancer, PRESSE MED, 28(39), 1999, pp. 2145-2148
Authors:
Viens, P
Palangie, T
Janvier, M
Fabbro, M
Roche, H
Delozier, T
Labat, JP
Linassier, C
Audhuy, B
Feuilhade, F
Costa, B
Delva, R
Cure, H
Rousseau, F
Guillot, A
Mousseau, M
Ferrero, JM
Bardou, VJ
Jacquemier, J
Pouillart, P
Citation: P. Viens et al., First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial), BR J CANC, 81(3), 1999, pp. 449-456
Authors:
Penault-Llorca, F
Dauplat, J
Levrel, O
Pomel, C
Kwiatkowski, F
Clemenson, A
Fouilhoux, G
De Latour, M
Cure, H
Fonck, Y
Citation: F. Penault-llorca et al., Evaluation of different grading systems for ovarian epithelial carcinoma in a series of 100 patients with uniform treatment and follow-up, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 277-280
Risultati:
1-17
|